Virios Therapeutics, Inc. , a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response.
Virios Therapeutics stock last closed at $0.47, up 2.85% from the previous day, and has decreased 39.48% in one year. It has underperformed other stocks in the Biotechnology industry by 0.17 percentage points. Virios Therapeutics stock is currently +68.1% from its 52-week low of $0.28, and -80.62% from its 52-week high of $2.42.
As of Apr 26, 2024, there are 19.26M shares of VIRI outstanding. The market cap of VIRI is $9.03M. In the past 24 hours, 39,799 VIRI shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy VIRI stock.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of shares by opening an account with eToro now.
Open eToro AccountNow that you've selected your brokerage, it's time to fill out some personal info so you are able to invest in VIRI stock today.
Now that you have filled out your info on our top ranked stock app, you can securely and quickly fund your account:
Check out the walkthrough below to see the process of transferring funds into your investment account.
Once you have identified the best place to buy Virios Therapeutics stock, it's absolutely critical to analyze their stock before you invest, so you truly comprehend the risk as well as the upside.
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on VIRI's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge VIRI's true value.
Using relative valuations methods:
You can do additional valuation research on VIRI's stock here.
You can dig deeper into what analysts are saying on the Virios Therapeutics stock forecast page.
Over the past year, executives and large shareholders at VIRI have bought more shares than they have sold.
William Pridgen, Director of VIRI, was the latest VIRI insider to buy. They bought $19,996.84 worth of VIRI stock on Aug 21, 2023.
Get more info about who owns VIRI stock here.
No, Virios Therapeutics doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two primary types of orders:
Press the Open button and eToro will execute your order.
If you want additional help with investing in stocks on eToro, click the helpful video below:
Now that you own some VIRI shares, you'll want to stay up-to-date on your new company.
Start a watchlist to see the latest developments about your VIRI stock.
To summarize, here are the 6 steps for buying Virios Therapeutics stock:
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest news on your new investment in Virios Therapeutics, add VIRI to your watchlist by clicking the button below.